| Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
| Risedronate sodium (substance) |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Risedronic acid (substance) |
Inferred relationship |
Some |
|
| Product containing risedronic acid (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Risedronic acid (substance) |
Inferred relationship |
Some |
1 |
| Product containing risedronic acid in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Risedronic acid (substance) |
Inferred relationship |
Some |
1 |
| Calcium- and risedronic acid-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Risedronic acid (substance) |
Inferred relationship |
Some |
2 |
| Product containing calcium and risedronic acid (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Risedronic acid (substance) |
Inferred relationship |
Some |
2 |
| Product containing only calcium and risedronic acid (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Risedronic acid (substance) |
Inferred relationship |
Some |
2 |
| Product containing only risedronic acid (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Risedronic acid (substance) |
Inferred relationship |
Some |
1 |
| Product containing only risedronic acid in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Risedronic acid (substance) |
Inferred relationship |
Some |
1 |
| Product containing only calcium and risedronic acid in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Risedronic acid (substance) |
Inferred relationship |
Some |
2 |
FHIR